Figure 1: Model of CDI transmission across three major subpopulations Objectives: The transmission of C. difficile infection (CDI) has recently changed, resulting in a five-fold increase in the incidence in the general population and an eight-fold increase among the elderly. We examined the relationship between three major subpopulations of CDI transmission: hospitals, long-term care facilities (LTCF), and communities, to evaluate treatment effectiveness and costs. Methods: We developed a decision analytic computer simulation model to compare various strategies for the management of CDI, across three major subpopulations of CDI transmission: hospitals, communities, and LTCFs. To estimate CDI rates in Canada, stratified by age and sex, by subpopulation (hospital, community, and LTCFs), and by primary vs. recurrent infections, we conducted a systematic analysis of all provincial and federal CDI data in Canada. Based on the reports, the incidence and recurrence rates, stratified by age, sex and the three subpopulations were estimated for Canada as a whole. We performed rigorous validation analyses to demonstrate that the estimated CDI rates are a reasonable representation of the selected actual rates for Canada. Results: We estimated the annual number of C. difficile infections at 21,632 cases, 75% in terms of new infections and the remaining in terms of recurrences. The rate per 100,000 population is estimated at 79, with 86 per 100,000 population among females, and 72 per 100,000 population among males. The rates per 100,000 population for ages 80 years and older are four-fold higher than for the 60-79 years old group. The recurrence rates are most pronounced among the elderly. We estimated that 69% of CDI cases occur in hospitals, 26% in community and 5% in LTFCs. The numbers of CDI cases among the elderly are expected to grow as the Canadian population ages. Conclusions: Our age-specific model allows to project and to quantify the impact of a CDI outbreak in terms of clinical burden and costs. Using a scenario-based approach, comparisons of current treatments with the novel approach of duodenal infusion (fecal transplant) are carried out. Our validated CDI model is also capable of estimating net clinical and economic benefits of new disinfection systems currently being evaluated and applied in various health care institutions across Canada. Clostridium difficile infection (CDI) is the leading cause of health care associated infectious diarrhea in hospitals. The disease spectrum caused by CDI ranges from a mild to a severe, life threatening, colitis. Until recently, CDI was considered to be a hospital based infection. The prevalence and severity of CDI are increasing; and CDI is now appearing in LTCFs, and the community. There are considerable gaps in the current understanding of CDI transmission between hospital, community, and LTCF settings. Advanced age has increasingly been identified as an important risk factor for CDI but little information is available on the effects of age and sex on clinical responses to CDI. Efforts to model CDI to date have been limited. Most models do not address the contribution of asymptomatic carriers as sources of new infections and are restricted to hospital acquired CDI. In the general population 5% -20% of adults are estimated to be asymptomatic carriers of CDI but up to 80% of the elderly are colonized in LTCFs. In 2005, 28% of CDI in Canada were among the population aged 80 and older. In 2011, 40% of infections occurred among patients aged 80+. Elderly patients experience more severe episodes of CDI. Age-specific recurrence rates of CDI are important characteristics of CDI. Patients over 65 experienced almost twice the recurrence rate compared with younger populations. We developed a decision analytic computer simulation model to compare various strategies for the management of CDI. Our objectives were (1) to examine systematically the dynamic relationship between three major subpopulations of CDI transmission: hospitals, communities, and LTCFs, and (2) to provide extensive model validation based on available provincial databases. We developed a decision analytic computer simulation model to compare various strategies for the management of CDI, between and within three major subpopulations of CDI transmission: hospitals, communities, and LTCFs (figure 1). To estimate CDI rates in Canada, stratified by age and sex, by subpopulation (hospital, community, and LTCFs), and by primary vs. recurrent infections, we conducted an extensive systematic analysis of all provincial and federal CDI data in Canada. The most recent data from four provinces, Quebec, Ontario, British Columbia, and Manitoba were considered to be relevant for the estimation of stratified CDI rates for Canada, as their combined populations represent over 75% of Canada’s population. We used piecewise polynomial interpolation to estimate annual stratified CDI rates across age, gender, subpopulation, and province. The fitted data consisted of a piecewise polynomial spline with three change points identified from the observed pattern of CDI for three age groups, 18-59 years, 60-79 years, and 80 years and over. Based on the provincial reports, the incidence and recurrence rates, stratified by age, sex and the three subpopulations were estimated for Canada as a whole. We calibrated the results of the analysis using selected provincial data, and goodness of fit measures were applied to all sets of predictive equations. We performed validation analyses to demonstrate that the CDI rates as predicted by the synthesized regression analyses are a reasonable representation of the selected actual rates for Canada. Predicted versus observed CDI rates were compared by age, gender, and subpopulation, using the following measures; number of cases, cases per 100,000 population, per 1,000 hospital admissions, and per 10,000 patient-days. We estimated the annual number of C. difficile infections at 21,632 cases, 75% in terms of new infections and the remaining in terms of recurrences. The rate per 100,000 population is estimated at 79, with 86 per 100,000 population among females, and 72 per 100,000 population among males. Figure 2 demonstrates that the peak number of cases occurs between ages 80-84 years. However, on a per population basis the rates are rapidly increasing starting from age 65 onward (figure 3). The rates per 100,000 population for ages 80 years and older are four-fold higher than for 60-79 years old group. The recurrence rates are most pronounced among the elderly. We estimated that 69% of CDI cases occur in hospitals, 26% in community and 5% in LTFCs. The number of CDI cases among the elderly are expected to grow as the Canadian population will age. The present distributions of CDI cases by various ages are 19% among 18-59 years old, 41% among 60-79, and 40% among those over 80 years old. We performed validation analyses to demonstrate that the predicted CDI rates were a reasonable representation of the selected actual rates for Canada. The CDI estimates were compared to selected data reported by the Canadian Nosocomial Infection Surveillance Program (CNISP), as a part of an independent validation. CNISP data was not used in the development of the model. Another external validation was performed using the Institute for Clinical Evaluative Sciences (ICES) and the Ontario Ministry of Health and Long-Term Care selected databases. Goodness of fit tests across nine age groups show a high degree of association between estimated and observed CDI rates. Our age-specific model of CDI transmission intends to (1) advance understanding of CDI transmission between the three subpopulations (hospital, community, and LTCF); (2) to improve the capacity to project and to quantify the impact of CDI in terms of clinical burdens and costs among these three subpopulations. Given the extensive validation, the model can be used for forecasting purposes using numerous scenarios, and will help identify patients at high risk for CDI. Currently, we are in the process of comparing clinical benefits and costs of current treatment regimens with promising novel approaches (e.g. fecal transplant). Our validated CDI model is also capable of estimating net benefits and costs of new disinfection systems currently being evaluated and applied in various health care institutions across Canada. Background